The opioid use disorder market involves medical products and therapies used to treat addiction and manage withdrawal symptoms associated with opioid abuse. Some key products in this market include buprenorphine, naltrexone, methadone, and various abuse-deterrent opioid formulations. The demand for these drugs and therapies has grown in recent years as the prevalence of opioid abuse and addiction has reached epidemic levels in various countries.

The global opioid use disorder market is estimated to be valued at US$ 3236.55 Mn in 2023 and is expected to exhibit a CAGR of 8.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:
The increased availability of more effective and long-acting treatment options presents a major market opportunity in the opioid use disorder market. Drugs like extended-release buprenorphine and six-month implant formulations help address relapse and non-adherence concerns associated with traditional treatment regimens. Their ability to provide lasting suppression of withdrawal symptoms and drug cravings can help more patients stay in remission long-term. This in turn can boost recurrence rates and support the continued scaling up of opioid addiction treatment services worldwide.

Porter’s Analysis
Threat of new entrants: The opioid use disorder market requires immense capital investments for Research & Development of new therapies. Stringent regulations in the pharmaceutical industry impose additional costs that deter new players.
Bargaining power of buyers: Individual opioid use disorder patients have limited influence over pricing and product offerings. However, pharmaceutical companies face pricing pressure from large healthcare providers and insurance companies.
Bargaining power of suppliers: The market involves few raw material suppliers and vendors of medical devices and treatment equipment have some influence over API and components pricing. This grants suppliers modest bargaining power.
Threat of new substitutes: Alternatives like psychotherapy and behavioral therapies pose a threat. However, they are not always as effective as medication therapy which limits their usage as perfect substitutes.
Competitive rivalry: The market involves many global players and generics manufacturers. Players engage in intensive efforts to develop novel therapies via collaborations and acquisitions to gain competitive advantages.

SWOT Analysis
Strengths: Growing awareness, strong R&D pipelines, increasing accessibility of treatments.
Weaknesses: Social stigma, risk of relapse, complex pathology necessitating multi-modal therapies.
Opportunities: Untapped emerging markets, scope for combination therapies, digital therapeutics.
Threats: Patent expiries of blockbuster drugs, pricing pressures, inconsistencies in regulations.

Key Takeaways
Global Opioid Use Disorder Market Demand is expected to witness high growth over the forecast period owing to rising prescription drug abuse and need for effective treatment options.

Regional analysis of the North America opioid use disorder market comprises the US and Canada. The US holds the lion’s share owing to growing public health crisis. According to CDC, opioid overdose claims over 100 American lives daily in the US. This has spurred government bodies and private players to boost funding for advanced therapeutics. Canada follows US trends and is working towards resolving inconsistencies in provincial policies governing opioid prescriptions and treatment access.

Key players operating in the opioid use disorder market are Moog Inc., Honeywell International Inc., AMETEK Inc., TE Connectivity, Woodward Inc., General Dynamics Corporation, Parker Hannifin Corp, Sensata Technologies, Tamagawa Seiki Co., Ltd., LTN Servotechnik GmbH. Major companies are focusing on launching novel MAT options such as buprenorphine and methadone drugs, extended-release injectables, as well as digital therapeutics to tap the high market potential.

Get More Insights on this Topic- https://www.dailyprbulletin.com/opioid-use-disorder-market-value-insights-and-forecast-analysis/